MTD:NYE-Mettler-Toledo International Inc (USD)

COMMON STOCK | Diagnostics & Research |

Last Closing

USD 1402.69

Change

+19.22 (+1.39)%

Market Cap

N/A

Volume

0.06M

Analyst Target

USD 865.00
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-18 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap
DHR Danaher Corporation

-0.57 (-0.21%)

USD 199.35B
IQV IQVIA Holdings Inc

+2.69 (+1.12%)

USD 43.52B
A Agilent Technologies Inc

+0.66 (+0.48%)

USD 39.94B
LH Laboratory Corporation of Amer..

+0.21 (+0.09%)

USD 18.96B
DGX Quest Diagnostics Incorporated

+0.10 (+0.06%)

USD 17.18B
CRL Charles River Laboratories

-0.11 (-0.05%)

USD 10.65B
QGEN Qiagen NV

+0.02 (+0.04%)

USD 10.30B
VNRX Volitionrx Ltd

-0.05 (-7.58%)

USD 0.06B
ENZ Enzo Biochem Inc

-0.01 (-0.89%)

USD 0.06B
TMO Thermo Fisher Scientific Inc

-0.37 (-0.06%)

N/A

ETFs Containing MTD

MCSE Martin Currie Sustainable.. 5.12 % 0.00 %

-0.19 (-0.79%)

N/A
EPRE 4.58 % 0.00 %

N/A

N/A
ASRP:XETRA BNP Paribas Easy ECPI Glo.. 2.39 % 0.00 %

-0.10 (-0.79%)

N/A
BMED BlackRock Future Health E.. 2.35 % 0.00 %

+0.08 (+-0.79%)

USD 4.21M
XMLC:F L&G Clean Water UCITS ETF 2.27 % 0.00 %

+0.29 (+-0.79%)

N/A
MEDTE:PA BNP Paribas Easy ECPI Glo.. 2.19 % 0.00 %

-0.09 (-0.79%)

N/A
MTUSD:PA BNP Paribas Easy ECPI Glo.. 2.19 % 0.00 %

-0.08 (-0.79%)

N/A
XLVE:CA Mulvihill U.S. Health Car.. 1.82 % 0.00 %

N/A

N/A
HECO 0.00 % 0.95 %

N/A

N/A
IBB iShares Biotechnology ETF 0.00 % 0.47 %

-0.31 (-0.79%)

USD 7.64B
QRI:CA 0.00 % 1.06 %

N/A

N/A
ZHU:CA BMO Equal Weight US Healt.. 0.00 % 0.00 %

+0.17 (+-0.79%)

CAD 0.01B
YXM.B:CA 0.00 % 0.69 %

N/A

N/A
ZUH:CA BMO Equal Weight US Healt.. 0.00 % 0.39 %

+0.14 (+-0.79%)

CAD 0.27B
MJJ 0.00 % 0.00 %

N/A

N/A
MJO 0.00 % 0.00 %

N/A

N/A
DWEQ 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Diagnostics & Research) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 15.64% 92% A 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.64% 92% A 70% C-
Trailing 12 Months  
Capital Gain 24.01% 92% A 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 24.01% 85% B 69% C-
Trailing 5 Years  
Capital Gain 97.79% 92% A 86% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 97.79% 92% A 84% B
Average Annual (5 Year Horizon)  
Capital Gain 16.79% 92% A 80% B-
Dividend Return 16.79% 92% A 78% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 30.88% 38% F 33% F
Risk Adjusted Return 54.37% 85% B 72% C
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.